NO20001830L - Ny kombinasjon - Google Patents

Ny kombinasjon

Info

Publication number
NO20001830L
NO20001830L NO20001830A NO20001830A NO20001830L NO 20001830 L NO20001830 L NO 20001830L NO 20001830 A NO20001830 A NO 20001830A NO 20001830 A NO20001830 A NO 20001830A NO 20001830 L NO20001830 L NO 20001830L
Authority
NO
Norway
Prior art keywords
new combination
inhibitor
cyclooxygenase
inflammation
administration
Prior art date
Application number
NO20001830A
Other languages
English (en)
Other versions
NO20001830D0 (no
Inventor
Peter Hamley
Alan Tinker
Original Assignee
Astrazeneca Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd
Publication of NO20001830D0 publication Critical patent/NO20001830D0/no
Publication of NO20001830L publication Critical patent/NO20001830L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Koadministrasjon av en inhibitor av indusert nitrogenoksydsyntase og en mhibitor av cyklooksygenase-2 for behandling av inflammasjon og inflammatoriske forstyrrelser.
NO20001830A 1997-10-10 2000-04-07 Ny kombinasjon NO20001830L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9703693A SE9703693D0 (sv) 1997-10-10 1997-10-10 Novel combination
PCT/SE1998/001792 WO1999018960A1 (en) 1997-10-10 1998-10-05 Novel combination

Publications (2)

Publication Number Publication Date
NO20001830D0 NO20001830D0 (no) 2000-04-07
NO20001830L true NO20001830L (no) 2000-05-10

Family

ID=20408563

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001830A NO20001830L (no) 1997-10-10 2000-04-07 Ny kombinasjon

Country Status (20)

Country Link
US (1) US6046191A (no)
EP (1) EP1027052A1 (no)
JP (1) JP2001519391A (no)
KR (1) KR20010031017A (no)
CN (1) CN1281362A (no)
AU (1) AU9469398A (no)
BR (1) BR9812753A (no)
CA (1) CA2305141A1 (no)
CZ (1) CZ20001272A3 (no)
EE (1) EE200000192A (no)
HU (1) HUP0003874A2 (no)
IL (1) IL135248A0 (no)
IS (1) IS5430A (no)
MX (1) MXPA00003445A (no)
NO (1) NO20001830L (no)
PL (1) PL339769A1 (no)
SE (1) SE9703693D0 (no)
SK (1) SK4282000A3 (no)
TR (1) TR200000928T2 (no)
WO (1) WO1999018960A1 (no)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701304D0 (sv) * 1997-04-09 1997-04-09 Astra Pharma Prod Compounds
EA200100125A1 (ru) * 1998-08-11 2001-08-27 Пфайзер Продактс Инк. Новое фармацевтическое применение ингибиторов соа
ATE283048T1 (de) 1999-12-08 2004-12-15 Pharmacia Corp Cyclooxygenase-2 hemmer enthaltende zusammensetzungen mit schnellem wirkungseintritt
CA2393724A1 (en) * 1999-12-23 2001-06-28 Nitromed, Inc. Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
GB0004153D0 (en) * 2000-02-23 2000-04-12 Astrazeneca Uk Ltd Novel use
US6589557B2 (en) * 2000-06-15 2003-07-08 Acusphere, Inc. Porous celecoxib matrices and methods of manufacture thereof
US6800297B2 (en) * 2000-06-15 2004-10-05 Acusphere, Inc. Porous COX-2 inhibitor matrices and methods of manufacture thereof
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
WO2002017896A2 (en) * 2000-08-29 2002-03-07 Peter Van Patten Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid
IN191090B (no) * 2000-08-29 2003-09-20 Ranbanx Lab Ltd
US7012098B2 (en) * 2001-03-23 2006-03-14 Pharmacia Corporation Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
US20030035795A1 (en) * 2001-04-13 2003-02-20 Gardell Stephen J. Methods for treating or reducing the risk of pain and inflammatory disorders by administering inhibitors of activated thrombin activatable fibrinolysis inhibitor
US20020187187A1 (en) * 2001-04-21 2002-12-12 Toshimitsu Ohki Fast disintegrating meloxicam tablet
AR035700A1 (es) * 2001-05-08 2004-06-23 Astrazeneca Ab Derivados de arilheteroalquilamina, composicion farmaceutica, usos de estos derivados para la fabricacion de medicamentos, metodos de tratamiento, y proceso para la preparacion de estos derivados
US20030114418A1 (en) * 2001-08-14 2003-06-19 Pharmacia Corporation Method for the treatment and prevention of pain and inflammation with glucosamine and a cyclooxygenase-2 selective inhibitor and compositions therefor
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
US20050049291A1 (en) * 2001-10-23 2005-03-03 Mukesh Kumar Process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2-enzyme inhibitors
ES2297032T3 (es) * 2001-11-13 2008-05-01 Pharmacia Corporation Forma de dosificacion oral de parecoxib.
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
KR20050005410A (ko) * 2002-02-19 2005-01-13 파마시아 코포레이션 요실금 치료용으로서의 시클로옥시게나제 저해제 및항무스카린제의 용도
WO2003103602A2 (en) * 2002-06-11 2003-12-18 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
AU2003261281A1 (en) * 2002-07-29 2004-02-16 Nicox S.A. Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1745791B1 (en) * 2003-05-07 2013-06-26 Osteologix A/S Treating cartilage/bone conditions with water-soluble strontium salts
ES2394782T3 (es) * 2003-05-07 2013-02-05 Osteologix A/S Composición con estroncio y vitamina D para la profilaxis y/o tratamiento de afecciones de cartílagos y/o huesos
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
AU2005254154A1 (en) * 2004-06-17 2005-12-29 Osteologix A/S Improving pain treatment with strontium combinations
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
AU2006298895B9 (en) * 2005-09-30 2013-01-24 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing meloxicam
RU2416603C9 (ru) 2005-10-25 2012-06-20 Сионоги Энд Ко., Лтд. Производные аминодигидротиазина
JP2007275193A (ja) * 2006-04-04 2007-10-25 Fujifilm Corp 光プローブおよび光断層画像化装置
GB0712287D0 (en) * 2007-06-22 2007-08-01 Ucl Business Plc Antimicrobial Conjugates
EP2052310A2 (en) * 2006-08-04 2009-04-29 UCL Business PLC Computer devices and accessories
CA2676413A1 (en) * 2007-01-19 2008-07-31 Mallinckrodt Inc. Diagnostic and therapeutic cyclooxygenase-2 binding ligands
EP2151435A4 (en) 2007-04-24 2011-09-14 Shionogi & Co PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE
EP2147914B1 (en) 2007-04-24 2014-06-04 Shionogi&Co., Ltd. Aminodihydrothiazine derivatives substituted with cyclic groups
DE102007049612A1 (de) * 2007-10-17 2009-06-10 Evonik Goldschmidt Gmbh Bioaktive Zusammensetzung für kosmetische Anwendungen
WO2009151098A1 (ja) 2008-06-13 2009-12-17 塩野義製薬株式会社 βセクレターゼ阻害作用を有する含硫黄複素環誘導体
CN102186841A (zh) 2008-10-22 2011-09-14 盐野义制药株式会社 具有bace1抑制活性的2-氨基嘧啶-4-酮及2-氨基吡啶衍生物
MX389960B (es) * 2009-10-12 2025-03-20 Boehringer Ingelheim Vetmedica Gmbh Recipientes para composiciones que comprenden meloxicam.
TWI488852B (zh) 2009-12-11 2015-06-21 Shionogi & Co 衍生物
CA2791805A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
JP5766198B2 (ja) 2010-10-29 2015-08-19 塩野義製薬株式会社 縮合アミノジヒドロピリミジン誘導体
JP5816630B2 (ja) 2010-10-29 2015-11-18 塩野義製薬株式会社 ナフチリジン誘導体
TW201247635A (en) 2011-04-26 2012-12-01 Shionogi & Co Oxazine derivatives and a pharmaceutical composition for inhibiting BAC1 containing them
EP2912035A4 (en) 2012-10-24 2016-06-15 Shionogi & Co DERIVATIVES OF DIHYDROOXAZINE OR OXAZEPINE HAVING BACE1 INHIBITING ACTIVITY

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996041645A1 (en) * 1995-06-12 1996-12-27 G.D. Searle & Co. Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations
DE69635048T2 (de) * 1995-06-12 2006-02-16 G.D. Searle & Co. Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
AU1952597A (en) * 1996-02-13 1997-09-02 G.D. Searle & Co. Combinations, having immunosuppressive effects, containing cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor

Also Published As

Publication number Publication date
US6046191A (en) 2000-04-04
PL339769A1 (en) 2001-01-02
JP2001519391A (ja) 2001-10-23
MXPA00003445A (es) 2001-06-01
EE200000192A (et) 2001-04-16
EP1027052A1 (en) 2000-08-16
SK4282000A3 (en) 2001-01-18
CN1281362A (zh) 2001-01-24
SE9703693D0 (sv) 1997-10-10
CZ20001272A3 (cs) 2000-09-13
HUP0003874A2 (hu) 2001-05-28
NO20001830D0 (no) 2000-04-07
BR9812753A (pt) 2000-08-29
AU9469398A (en) 1999-05-03
IS5430A (is) 2000-04-06
TR200000928T2 (tr) 2000-11-21
KR20010031017A (ko) 2001-04-16
CA2305141A1 (en) 1999-04-22
WO1999018960A1 (en) 1999-04-22
IL135248A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
NO20001830L (no) Ny kombinasjon
SE9802333D0 (sv) Novel combination
NO20083175L (no) Synergistisk analgetisk kombinasjon av opioid analgetikum og cyklooksigenase-2 inhibitor
TR200102499T2 (tr) Neoplazi tedavisinde bir kombinasyon terapisi olarak bir siklooksijenaz-2 inhibitörü ve bir veya daha fazla antineoplastik ajan kullanma yöntemi
IS5094A (is) Nituroxíð sýntasa latar, notkun og aðferð til framleiðslu þeirra, ásamt lyfjasamsetningum
ATE301457T1 (de) Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
NO990296D0 (no) HPPD-genet og inhibitorer
YU53899A (sh) Primena inhibitora ciklooksigenaze-2 u prevenciji kardiovaskularnih poremećaja
PT1084104E (pt) Inibidores da sintase de oxido nitrico
CY1106156T1 (el) Νεα χρηση βουδεσονιδης και φορμοτepολης
NO994778D0 (no) FremgangsmÕter og sammensetninger for behandling av tarmbetennelse
NO995544L (no) Forbindelser og metoder for inhibering av ekspresjonen av VCAM-1
ATE383769T1 (de) Inhibitoren des transkriptionsfaktors nf-kappa b
NO20030397L (no) Amyloid målsökende billeddannende midler og anvendelser av samme
TR199801511T2 (xx) Farmas�tik bile�im.
TR199900505T2 (no)
EE05056B1 (et) IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette n„htud ateroskleroosi ravimiseks ja/v?i ennetamiseks
DK0885188T3 (da) Hydroxyamidinoderivater, der kan anvendes som nitrogenoxidsynthaseinhibitorer
NO991619L (no) Anvendelse av en H+, K+-ATPase-inhibitor i behandlingen av nesepolypper
BR9907655A (pt) Derivados de ácido di-hidróxi-hexanóico
TR199901703T2 (xx) Siklooksijenaz-2 inhibit�rlerini anti-anjiyojenik ajanlar olarak kullanma y�ntemi.
ATE254917T1 (de) Mittel gegen parasitäre protozoen
NO20010291D0 (no) Coadministrasjon av ACAT og MMP inhibitorer for behandling av aterosklerotiske sår
NO20023737L (no) Fremgangsmåte og preparater for behandling av en inflammatorisk lidelse
NO20005147L (no) FremgangsmÕter og sammensetninger som benytter terfenadinmetabolitter i kombinasjon med leukotrienhemmere

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application